Genetic Humanization by OzBIG: Complete Transgenic Replacement of Any Gene for Improved Translation of Preclinical Research
Genetic Humanization by OzBIG: Complete Transgenic Replacement of Any Gene for Improved Translation of Preclinical Research
Genetic Humanization by OzBIG: Complete Transgenic Replacement of Any Gene for Improved Translation of Preclinical Research
Genetic Humanization by OzBIG: Complete Transgenic Replacement of Any Gene for Improved Translation of Preclinical Research
Join us for an exclusive scientific webinar showcasing OzBIG — Ozgene’s next-generation gene replacement technology that enables complete transgenic replacement of any gene in mouse models. OzBIG was developed to overcome the limitations of standard knock-in and partial replacement methods, providing a new path to genetic humanization with superior translational relevance.
🔗 Register now to reserve your place and receive the on-demand recording.
In this session, we’ll explore:
- The evolution of genetic humanization: gene-based vs. tissue-based approaches
- Why traditional knock-in strategies often fall short in preclinical research
- How OzBIG resolves key barriers in genetic humanization
- OzBIG’s streamlined workflow — from project planning to execution
- Case studies and published examples of OzBIG’s impact in translational research
- Live Q&A with our scientific team
This webinar is ideal for researchers in:
- Drug discovery and development
- Rare and monogenic diseases
- Translational biology and preclinical modeling
- Biotech, biopharma, and academic research
Event Details (Perth)
📍Location: Online via Microsoft Teams
🗓 Date: 12 November 2026
⏰Time: 10:00 AM PST / 1:00 PM EST
Presenters (4)
Roger Askew
Ozgene Pty Ltd
Jonathan Gauntlett
Ozgene Pty Ltd
Kenn Albrecht
CEO
Dr. Harald Kranz
CEO